Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Madrigal Pharmaceuticals (MDGL) FCF Margin (2019 - 2025)

Historic FCF Margin for Madrigal Pharmaceuticals (MDGL) over the last 8 years, with Q3 2025 value amounting to 27.5%.

  • Madrigal Pharmaceuticals' FCF Margin rose 1364900.0% to 27.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 21.82%, marking a year-over-year increase of 5423000.0%. This contributed to the annual value of 253.72% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Madrigal Pharmaceuticals reported FCF Margin of 27.5% as of Q3 2025, which was up 1364900.0% from 22.11% recorded in Q2 2025.
  • Madrigal Pharmaceuticals' FCF Margin's 5-year high stood at 27.5% during Q3 2025, with a 5-year trough of 922.78% in Q2 2024.